Health care pharmaceutical companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Grifols has the lowest figure of the 50 health care pharmaceutical companies ranked by P/S ratio, at 0.7, followed by Viatris (1.6) and GSK (2.2). Figures as of 19 Nov 2026, 22:46 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 50
- Lowest
- Grifols0.7
- Median
- 6.7
- Combined market value
- TRY 250.68T
- Countries
- 10
- Not ranked
- 11no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | GrifolsGRFS · Health Care | 0.7 | TRY 281.9B | TRY 414.23 | 3.19% down | 0% up | ||
| 2 | ViatrisVTRS · Health Care | 1.6 | TRY 1.15T | TRY 1,004.26 | 1.97% down | 99% up | ||
| 3 | GSKGSK · Health Care | 2.2 | TRY 4.84T | TRY 2,415.68 | 1.56% down | 5% up | ||
| 4 | SanofiSNY · Health Care | 2.3 | TRY 5.59T | TRY 2,326.77 | 2.25% down | 4% down | ||
| 5 | Takeda PharmaceuticalTAK · Health Care | 2.4 | TRY 3.46T | TRY 1,081.55 | 0.66% up | 51% up | ||
| 6 | Amneal PharmaceuticalsAMRX · Health Care | 2.5 | TRY 376.5B | TRY 1,080.54 | 2.24% down | 90% up | ||
| 7 | Bristol-Myers SquibbBMY · Health Care | 2.5 | TRY 6.02T | TRY 2,947.11 | 2.05% down | 30% up | ||
| 8 | PfizerPFE · Health Care | 2.5 | TRY 7.93T | TRY 1,391.21 | 1.85% down | 15% up | ||
| 9 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.6 | TRY 2.27T | TRY 1,946.89 | 8.74% down | 74% up | ||
| 10 | Elanco Animal HealthELAN · Health Care | 2.8 | TRY 663.8B | TRY 1,328.07 | 1.54% down | 26% up | ||
| 11 | PTC TherapeuticsPTCT · Health Care | 2.8 | TRY 246.2B | TRY 2,946.35 | 3.16% down | 21% down | ||
| 12 | Legend BiotechLEGN · Health Care | 3.0 | TRY 157.8B | TRY 813.31 | 0.92% down | 41% down | ||
| 13 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.5 | TRY 624.5B | TRY 749.15 | 1.00% down | 8% up | ||
| 14 | ZoetisZTS · Health Care | 3.5 | TRY 1.66T | TRY 4,081.20 | 5.59% down | 26% down | ||
| 15 | Jazz PharmaceuticalsJAZZ · Health Care | 3.6 | TRY 766.7B | TRY 11,944.53 | 4.57% down | 41% up | ||
| 16 | BioMarin PharmaceuticalBMRN · Health Care | 3.7 | TRY 601B | TRY 3,102.70 | 0.02% down | 17% up | ||
| 17 | Novo NordiskNVO · Health Care | 3.7 | TRY 8.65T | TRY 1,963.56 | 1.42% down | 17% down | ||
| 18 | Abbott LaboratoriesABT · Health Care | 4.1 | TRY 9.09T | TRY 5,247.11 | 0.58% down | 16% down | ||
| 19 | AstraZenecaAZN · Health Care | 4.6 | TRY 13.74T | TRY 8,861.03 | 1.87% down | 1% up | ||
| 20 | Ionis PharmaceuticalsIONS · Health Care | 4.8 | TRY 229B | TRY 1,375.05 | 0.62% down | 63% down | ||
| 21 | Merck & CoMRK · Health Care | 5.0 | TRY 16.54T | TRY 6,709.04 | 3.61% down | 45% up | ||
| 22 | NovartisNVS · Health Care | 5.2 | TRY 14.43T | TRY 7,639.04 | 2.57% down | 25% up | ||
| 23 | AlkermesALKS · Health Care | 5.3 | TRY 392B | TRY 2,332.83 | 1.43% down | 66% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | 5.3 | TRY 1T | TRY 7,467.29 | 1.06% down | 66% down | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | 6.7 | TRY 4.83T | TRY 46,643.54 | 2.35% down | 28% up | ||
| 26 | Johnson & JohnsonJNJ · Health Care | 6.8 | TRY 32.49T | TRY 13,494.87 | 2.04% down | 34% up | ||
| 27 | Arrowhead PharmaceuticalsARWR · Health Care | 7.4 | TRY 311.7B | TRY 2,205.03 | 1.25% up | 13% up | ||
| 28 | United TherapeuticsUTHR · Health Care | 7.5 | TRY 1.2T | TRY 28,243.55 | 3.16% down | 22% up | ||
| 29 | AbbVieABBV · Health Care | 8.2 | TRY 25.32T | TRY 14,323.33 | 0.86% down | 25% up | ||
| 30 | GenmabGMAB · Health Care | 8.5 | TRY 1.6T | TRY 2,594.00 | 0.75% up | 70% up | ||
| 31 | BeOne MedicinesONC · Health Care | 8.5 | TRY 2.31T | TRY 20,191.29 | 0.97% down | 16% up | ||
| 32 | Corcept TherapeuticsCORT · Health Care | 9.3 | TRY 359.3B | TRY 3,282.54 | 4.15% down | 10% down | ||
| 33 | Travere TherapeuticsTVTX · Health Care | 9.4 | TRY 234.2B | TRY 2,439.93 | 3.86% down | 45% up | ||
| 34 | Madrigal PharmaceuticalsMDGL · Health Care | 9.6 | TRY 465.6B | TRY 20,041.76 | 0.34% down | 27% down | ||
| 35 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 10.8 | TRY 371.3B | TRY 4,725.02 | 1.59% down | 129% up | ||
| 36 | Vertex PharmaceuticalsVRTX · Health Care | 11.0 | TRY 6.67T | TRY 26,301.71 | 2.94% down | 27% up | ||
| 37 | Axsome TherapeuticsAXSM · Health Care | 11.2 | TRY 360.5B | TRY 6,854.02 | 1.25% up | 6% down | ||
| 38 | Mirum PharmaceuticalsMIRM · Health Care | 12.0 | TRY 315B | TRY 4,824.79 | 3.27% up | 34% up | ||
| 39 | TG TherapeuticsTGTX · Health Care | 15.9 | TRY 495.4B | TRY 3,277.48 | 1.88% down | 117% up | ||
| 40 | Royalty PharmaRPRX · Health Care | 16.4 | TRY 1.97T | TRY 3,420.95 | 1.38% down | 79% up | ||
| 41 | Eli LillyLLY · Health Care | 18.5 | TRY 60.8T | TRY 68,253.31 | 2.29% down | 33% up | ||
| 42 | Ascendis PharmaASND · Health Care | 21.0 | TRY 848.2B | TRY 12,930.10 | 5.32% down | 29% up | ||
| 43 | Ligand PharmaceuticalsLGND · Health Care | 21.4 | TRY 289.9B | TRY 14,495.09 | 3.94% down | 50% up | ||
| 44 | BridgeBio PharmaBBIO · Health Care | 30.3 | TRY 769.3B | TRY 3,949.35 | 0.22% up | 21% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | 42.7 | TRY 409.1B | TRY 5,900.28 | 1.88% down | 18% up | ||
| 46 | InsmedINSM · Health Care | 52.3 | TRY 1.6T | TRY 7,297.56 | 20.58% up | 40% down | ||
| 47 | CytokineticsCYTK · Health Care | 81.4 | TRY 362.1B | TRY 2,599.56 | 0.27% up | 19% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | 176 | TRY 408.9B | TRY 6,265.01 | 2.47% down | 51% up | ||
| 49 | Dianthus TherapeuticsDNTH · Health Care | 2346 | TRY 241.3B | TRY 4,285.28 | 1.01% up | 108% up | ||
| 50 | Roivant SciencesROIV · Health Care | 3418 | TRY 1.43T | TRY 1,968.11 | 0.59% up | 91% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 50.5161 TRY). 11 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care pharmaceutical companies have the lowest P/S ratio?
Grifols (0.7), Viatris (1.6) and GSK (2.2) have the lowest P/S ratio of the 50 health care pharmaceutical companies ranked here as of 19 Nov 2026, 22:46 UTC.
How many health care pharmaceutical companies are in this ranking?
50 are ranked by P/S ratio. 11 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care pharmaceutical companies worth together?
The 50 health care pharmaceutical companies ranked by P/S ratio have a combined market value of TRY 250.68T as of 19 Nov 2026, 22:46 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care pharmaceutical companies by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.